Evermay Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-330
Closed -$20.8K 585
2024
Q3
$20.8K Sell
330
-2,137
-87% -$125K ﹤0.01% 397
2024
Q2
$146K Sell
2,467
-125
-5% -$7.82K 0.02% 221
2024
Q1
$207K Sell
2,592
-735
-22% -$56.1K 0.03% 200
2023
Q4
$263K Buy
3,327
+32
+1% +$2.28K 0.05% 155
2023
Q3
$230K Hold
3,295
0.05% 156
2023
Q2
$228K Buy
3,295
+1,012
+44% +$72K 0.04% 165
2023
Q1
$170K Sell
2,283
-356
-13% -$29.9K 0.03% 190
2022
Q4
$246K Buy
2,639
+414
+19% +$39.9K 0.05% 148
2022
Q3
$212K Hold
2,225
0.04% 156
2022
Q2
$206K Hold
2,225
0.04% 156
2022
Q1
$225K Buy
2,225
+15
+0.7% +$1.58K 0.04% 177
2021
Q4
$228K Buy
2,210
+125
+6% +$11.6K 0.04% 159
2021
Q3
$177K Sell
2,085
-1,450
-41% -$121K 0.03% 173
2021
Q2
$295K Buy
3,535
+30
+0.9% +$2.46K 0.05% 147
2021
Q1
$264K Buy
3,505
+70
+2% +$5.1K 0.05% 150
2020
Q4
$235K Buy
+3,435
New +$223K 0.05% 156
2020
Q3
Sell
-3,385
Closed -$220K 158
2020
Q2
$220K Buy
+3,385
New +$213K 0.06% 146

Other funds holding CVS

Evermay Wealth Management's CVS Position: Q4 2024 in Review

Evermay Wealth Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 330 shares — an estimated $20.8K sold.

Evermay Wealth Management first reported a position in CVS in Q2 2020 and held it in 17 quarters. The position peaked at $295K in Q2 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Evermay Wealth Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Evermay Wealth Management sold 330 CVS Health shares in Q4 2024, an estimated $20.8K.
  • Evermay Wealth Management first reported a position in CVS Health in Q2 2020 and held it in 17 quarters.
  • Evermay Wealth Management's CVS Health position peaked at $295K in Q2 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Evermay Wealth Management's 13F filing for Q4 2024, filed 24 Jan 2025.